Migraines & Headaches
Clinical research
​
2024: In a survey of 1300+ people from a tertiary headache center, they reported using cannabis to treat their headaches & sleep concerns with the majority reporting improvements in migraine intensity, duration & frequency as well as nausea, sleep disturbances, anxiety & depression
Characterizing Cannabis Use and Perceived Benefit in a Tertiary Headache Center Patient Sample
https://pubmed.ncbi.nlm.nih.gov/38455123/
​
2024: In people with migraines, 600 mg of PEA resolved headaches, lowered pain & reduced rescue medication significantly more than a placebo with no adverse events
Effectiveness of Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants—A Double-Blind Randomised Controlled Study
https://www.mdpi.com/1424-8247/17/2/145
​
2024: For migraines, a vaped THC/CBD mixture caused sustained pain relief
Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial
https://pubmed.ncbi.nlm.nih.gov/38405890/
​
2024: For refractory migraine (resistant to treatment), a case report of one month of CBD resolving the symptoms
Cannabidiol in the treatment of migraine: studies and future perspectives
https://headachemedicine.com.br/index.php/hm/article/view/1270
​
2022: In a survey of people with persistent headaches, the majority of cannabis users reported it helped with the severity of their headaches & a quarter of them said it reduced their frequency
Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey
https://pubmed.ncbi.nlm.nih.gov/34511153
​
2022: In migraine patients, oral cannabinoids helped reduce pain intensity & to lower acute medication intake
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study
https://pubmed.ncbi.nlm.nih.gov/34347088/
​
2022: In humans with tension headaches, PEA worked almost as well as ibuprofen for moderate headaches & for severe headaches, PEA worked faster
Efficacy of Palmitoylethanolamide (Levagen+TM) Compared to Ibuprofen for Reducing Headache Pain Severity and Duration in Healthy Adults: A Double-Blind, Parallel, Randomized Clinical Trial
https://www.scirp.org/journal/paperinformation.aspx?paperid=118715
​
2022: In patients with episodic migraines, a small pilot study finds that PEA helps decrease the frequency of migraines & the amount of medication needed for pain
Palmitoylethanolamide-based nutraceutical Calmux® in preventive treatment of migraine
https://pubmed.ncbi.nlm.nih.gov/35598579
​
2021: In this case study, vaping a small amount of THC helped a patient with her headaches resulting from brain surgery
Significant reduction of symptomatic headache by medical marijuana – Case report
​
2020: A survey finds cannabis helpful for migraines
Experience of Migraine, its Severity, and Perceived Efficacy of Treatments among Cannabis Users
https://www.sciencedirect.com/science/article/pii/S0965229920318860
​
2020: A real-world study finds smoked cannabis flower effective for migraines & headache
Alleviative effects of Cannabis flower on migraine and headache
https://www.sciencedirect.com/science/article/abs/pii/S2095496420300741
​
2020: A study finds that cannabis treatment decreased migraine frequency
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
https://www.mdpi.com/2076-3425/10/6/360
​
2016: A retrospective chart review of migraine patients shows cannabis decreased migraine frequency
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
https://www.ncbi.nlm.nih.gov/pubmed/26749285
​
Chart gallery
2024 Interplay between cannabinoids and the neuroimmune system in migraine
2022 Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic Review
2018 Emerging Role of (Endo)Cannabinoids in Migraine
2024 Interplay between cannabinoids and the neuroimmune system in migraine
Best reviews
​
2024: A review of cannabis for the treatment of headaches
Cannabis Use in Headache Treatment: A Literature Review
https://headachemedicine.com.br/index.php/hm/article/view/872
​
2024: For migraines, a review of the neural immune cells & the effects of the cannabinoids (good charts on the immune system)
Interplay between cannabinoids and the neuroimmune system in migraine
https://link.springer.com/article/10.1186/s10194-024-01883-3
​
2023: For migraines, this review of nine studies finds cannabis to cause a significant clinical reduction in their length & frequency
Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic Review
https://pubmed.ncbi.nlm.nih.gov/36660507/
​
2022: A review of the evidence suggests the promising benefits of cannabis for migraine
Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence
https://pubmed.ncbi.nlm.nih.gov/35711271
​
2021: This review of migraines & neural inflammation has a focus on the pain-relieving ability of the endocannabinoids (good charts of migraines)
Neurogenic Inflammation: One of the Participants of Migraine and the Contribution of Translational Research
https://www.preprints.org/manuscript/202111.0064/v1
​
2008: Dr. Ethan Russo on the history of cannabis for migraines
Hemp for Headache An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment
​
Timeline of research
​
2024: In a rat model of migraines, CBD worked roughly as well as the pharmaceutical treatment drugs sumatriptan & cafiaspirin
Study on the Effects of Isolated Cannabidiol on Vascular Cephalalgia in an Experimental Model of Induced Migraine in Wistar Rats
https://www.neurology.org/doi/abs/10.1212/WNL.0000000000205743
​
2024: In a female rat model of migraines, CBD/THC reduced pain & photosensitivity to light with some benefits with the addition of CBG
Potential antinociceptive effects of cannabinoid compounds on migraine-associated responses in an experimental model in female rats
https://www.headachemedicine.com.br/index.php/hm/article/view/1062
​
2024: In a mouse model of headaches, they had dysregulations of their endocannabinoid system
Formoterol dynamically alters endocannabinoid tone in the periaqueductal gray inducing headache
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01907-y
​
2024: In a mouse model of migraines, zolmitriptan patches reduced pain via the CB1 receptors
Zolmitriptan niosomal transdermal patches: combating migraine via epigenetic and endocannabinoid pathways and reversal of migraine hypercoagulability
https://link.springer.com/article/10.1007/s13346-024-01731-6
​
2024: In a tissue model of familial hemiplegic migraine (migraine with aura & motor weakness), CBD reduced the excitability of the hyperactive sodium channels linked to the disease
Cannabidiol as a Potential Treatment for Familial Hemiplegic Migraines
https://journals.lib.sfu.ca/index.php/ugrs/article/view/6347
​
2023: In a rat model of acute & chronic migraines, CBD significantly reduced pain & inflammation levels in the acute model & CBD caused a significant decrease in inflammatory cytokines in the chronic model
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
https://pubmed.ncbi.nlm.nih.gov/37138206/
​
2023: In a mouse model of migraines, CBD helped with the pain though it only helped the males with the related anxiety & pain behaviors
Preclinical effects of cannabidiol in an experimental model of migraine
https://pubmed.ncbi.nlm.nih.gov/37310430/
​